The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
26
Drug is administered
Drug is administered
Duke University
Durham, North Carolina, United States
NOT_YET_RECRUITINGHealth Sciences Centre
Winnipeg, Manitoba, Canada
RECRUITINGWASO
Wake After Sleep Onset (recorded using PSG)
Time frame: 36 Days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.